Researchers at Perm National Research Polytechnic University, known as PNIPU, have developed a cold plasma device intended to treat wounds and skin diseases, according to a report to Gazeta.ru from the university’s press service. The news describes how the technology works, its current testing phase, and its potential to change how certain skin conditions are managed.
Open data indicates that roughly 15 to 20 percent of people in Russia suffer from dermatological problems such as acne, eczema, psoriasis and fungal infections. Traditional treatments, including antibiotics and anti-inflammatory drugs, can lead to side effects like dysbiosis and systemic reactions that affect allergies and organs. These challenges motivate researchers to explore safer, more targeted alternatives for skin health.
Unlike lasers, cold plasma covers a broad spectrum that ranges from ultraviolet to infrared. This enables simultaneous disinfection, stimulation of tissue regeneration, and controlled heating without the risk of overheating. The surface temperature of the plasma remains near room temperature, contributing to safety during skin procedures.
In trials conducted at Perm Polytechnics, real patients were treated with the device. In these early studies, sessions lasting three to seven minutes showed accelerated wound healing, reduced inflammation, and suppression of pathogenic microflora. The technology proved effective against acne, herpes-related rashes, trophic ulcers, and open wounds.
The device is currently advancing through preclinical research under the supervision of Academician EA Wagner. The researchers anticipate its potential use for patients with long-healing sores and a variety of chronic skin diseases in the future.
Earlier Russian scientists pursued methods to reduce harmful emissions in aviation and energy, reflecting a broader pattern of applying scientific innovation to both health and environmental challenges.
If the technology proves successful beyond current studies, it could eventually find applications in Canada and the United States, subject to regulatory approvals and further clinical validation. The research aligns with a growing interest in non-thermal plasma medicine as a non-invasive option for dermatology and wound care.
As the field evolves, researchers emphasize rigorous testing, safety assessments, and scalable production considerations to ensure the device can meet clinical needs while maintaining high safety standards. The ongoing work underscores how plasma-based approaches may complement existing therapies and offer new paths for healing and skin health.